Stay updated on Dupilumab in AFRS Clinical Trial
Sign up to get notified when there's something new on the Dupilumab in AFRS Clinical Trial page.

Latest updates to the Dupilumab in AFRS Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed objectives and criteria for a clinical study on dupilumab for allergic fungal rhinosinusitis, while adding a new registry identifier and a revision number.SummaryDifference27%
- Check30 days agoChange DetectedThe web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to March 24, 2025.SummaryDifference0.2%
- Check38 days agoChange DetectedThe page has been updated to reflect a new version, v2.14.3, with the last update date changed to March 25, 2025, replacing the previous version v2.14.2 dated March 24, 2025.SummaryDifference0.2%
- Check45 days agoChange DetectedThe page has been updated with new dates for events, including specific dates in March 2025, while previous dates have been removed. The status of recruitment has also changed from 'Active, not recruiting' to 'Completed'.SummaryDifference1%
- Check74 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
Stay in the know with updates to Dupilumab in AFRS Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dupilumab in AFRS Clinical Trial page.